Orthofix Medical Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名32/207位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價22.80。中期看,股價處於平穩狀態。近一個月,市場表現較差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。
Orthofix Medical Inc評分
相關信息
行業排名
32 / 207
全市場排名
115 / 4563
所屬行業
醫療設備與耗材
壓力支撐
由於公司未披露,未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
5
分析師
買入
評級
22.800
目標均價
+45.87%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議
Orthofix Medical Inc亮點
亮點風險
Orthofix Medical Inc. is a global medical technology company. The Company offers a portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH navigation system. The Company’s Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. The segment provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Orthopedics segment offers products and solutions for limb deformity correction and complex limb reconstruction with a focus on use in trauma, adult and pediatric limb reconstruction, and foot and ankle procedures.
Orthofix Medical Inc. is a global medical technology company. The Company offers a portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH navigation system. The Company’s Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. The segment provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Orthopedics segment offers products and solutions for limb deformity correction and complex limb reconstruction with a focus on use in trauma, adult and pediatric limb reconstruction, and foot and ankle procedures.
公司代碼OFIX
公司Orthofix Medical Inc
CEOCalafiore (Massimo)
網址https://ir.orthofix.com/ir-home/default.aspx
常見問題
Orthofix Medical Inc(OFIX)的當前股價是多少?
Orthofix Medical Inc(OFIX)的當前股價是 15.240。
Orthofix Medical Inc 的股票代碼是什麼?
Orthofix Medical Inc的股票代碼是OFIX。
Orthofix Medical Inc股票的52週最高點是多少?
Orthofix Medical Inc股票的52週最高點是20.480。
Orthofix Medical Inc股票的52週最低點是多少?
Orthofix Medical Inc股票的52週最低點是10.240。
Orthofix Medical Inc的市值是多少?
Orthofix Medical Inc的市值是602.27M。
Orthofix Medical Inc的淨利潤是多少?
Orthofix Medical Inc的淨利潤為-126.00M。
現在Orthofix Medical Inc(OFIX)的股票是買入、持有還是賣出?
根據分析師評級,Orthofix Medical Inc(OFIX)的總體評級為買入,目標價格為22.800。
Orthofix Medical Inc(OFIX)股票的每股收益(EPS TTM)是多少
Orthofix Medical Inc(OFIX)股票的每股收益(EPS TTM)是-3.031。